Biopharmaceutical company Sorrento Therapeutics has has its Covid-19 rapid antigen test COVI-STIX placed on the official list of point-of-care rapid antigen tests approved for emergency use in Mexico. According to InDRE, an independent government testing laboratory in Mexico, COVI-STIX outperformed among the tests for both sensitivity and specificity. Sorrento has begun all import and commercial roll-out activities and is expecting the test to be available for customers within weeks.
Applied DNA Clinical Labs has secured a safeCircle pooled Covid-19 surveillance testing contract with Camp Chateaugay, a summer camp programme for teenagers and kids in New York’s Adirondack Mountain region. The acquisition is indicative of the re-opening of places for opportunities in which Covid-19 pooled surveillance testing aims at lowering the risk of virus spread.
Go deeper with GlobalData
Eurobio Scientific, a French group specialising in in-vitro medical diagnostics, announced that the company will begin marketing its new proprietary test EBS 1005, a self-administered Covid-19 antigen test. The test has also received a waiver to be marketed until it receives a CE marking, and is expected to be sold in sets of five across pharmacies or under government contracts.
